Meeting
2022 ASCO Annual Meeting
STRIVE-02: A first-in-human phase 1 trial of systemic B7H3 CAR T cells for children and young adults with relapsed/refractory solid tumors.
Authors
Navin R. Pinto
Seattle Children's Hospital, Seattle, WA
Navin R. Pinto , Catherine Michelle Albert , Mallory Taylor , Ashley Wilson , Stephanie Rawlings-Rhea , Wenjun Huang , Kristy Seidel , Prabha Narayanaswany , Vicky Wu , Christopher Brown , Nicholas A. Vitanza , Rimas Orentas , Rebecca Alice Gardner , Michael C. Jensen , Julie R. Park
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Clinical Trial Registration Number
NCT04483778
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10011)
DOI
10.1200/JCO.2022.40.16_suppl.10011
Abstract #
10011
Poster Bd #
226
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment.
First Author: Navin R. Pinto
Poster
2023 ASCO Annual Meeting
A phase 1 dose escalation study of GCC19CART: A novel coupled CAR therapy for patients with metastatic colorectal cancer.
First Author: Lei Xiao
Poster
2022 ASCO Annual Meeting
A phase 1 dose-escalation study of GCC19 CART a novel coupled CAR therapy for subjects with metastatic colorectal cancer.
First Author: Jiuwei Cui
Poster
2023 ASCO Annual Meeting
Safety and efficacy profile of a very low dose of MC-1-50 for treatment of r/r NHL.
First Author: Shiqi Li